Industries > Pharma > Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies

PUBLISHED: 04 March 2020
PAGES: 179
PRODUCT CODE: PHA0629
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0629 Categories: , Tags: , , ,

covid-19

Market Dynamics
• Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
• Increasing outsourcing of biopharmaceuticals-related manufacturing activities
• Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
• Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
• Uptake of single-use production systems by the biopharmaceutical manufacturing industry
• Asia emerging as hot destination for biopharmaceutical manufacturing
• Increasing confidence of pharmaceutical industry in CDMOs capabilities
• High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs
• Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
• Increasing shortage of skilled workforce in the biopharmaceutical industry
• Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
• Complicated and stringent regulatory requirements hinder market growth

Market Segmentation 2020-2030
Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service

• Process Development
– Downstream
– Upstream

• Fill & Finish Operations
• Analytical & Quality Control Studies
• Packaging

Product

• Biologics
– Monoclonal Antibodies (MAbs)
– Recombinant Proteins
– Vaccines
– Insulin

• Biosimilars

Regional Breakdown
Focused regional forecasts and analysis explore the future opportunities:

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

• North America
– U.S.
– Canada

• Europe
– UK
– France
– Germany
– Russia
– Rest of Europe

• Asia-Pacific
– China
– Japan
– India
– Southeast Asia
– Rest of Asia Pacific

• Latin America
– Brazil
– Argentina
– Rest of Latin America

• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East

Buy our report today Biopharmaceuticals Contract Manufacturing Market Report 2020-2030: Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category